Target intelligence / Profile preview

Cellular self-renewal

Molecular classification
Biological process, Phenotype
01

Overview

Cellular self-renewal is the fundamental biological process by which a stem cell undergoes division to produce at least one daughter cell that retains the same undifferentiated state and developmental potential as the parent cell (He et al., 2009, Nature). This process is essential for maintaining the stem cell pool throughout the lifespan of an organism, ensuring continuous tissue repair and homeostasis (NIH Stem Cell Information). Self-renewal is tightly regulated by an intricate network of signaling pathways, including Wnt/beta-catenin, Notch, and Hedgehog, as well as core transcription factors like OCT4, SOX2, and NANOG. In a clinical context, 'cellular self-renewal' is not a single molecular target but a complex phenotype. Dysregulation of these pathways is a hallmark of cancer, where 'cancer stem cells' (CSCs) hijack self-renewal mechanisms to drive tumor initiation, progression, and resistance to chemotherapy (Reya et al., 2001, Nature). While drugs like Glasdegib target specific components of these pathways (e.g., Smoothened) to inhibit CSC maintenance, the process itself involves a broad array of molecular players and is not classified as a discrete therapeutic target.

Other names
Stem cell self-renewalStemness maintenanceSymmetric stem cell divisionSelf-replacement
02

Mechanism of action

Not applicable as a single mechanism; therapeutic intervention typically involves the inhibition of signaling pathways (e.g., Hedgehog, Wnt, Notch) or transcription factors that maintain the self-renewing state of stem cells.

03

Biological functions

Stem cell maintenanceTissue homeostasisDevelopmental biologyRegenerative medicineCell cycle regulation
04

Disease associations

Cancer (Cancer Stem Cells)Degenerative diseasesAgingHematological malignancies
05

Safety considerations

Impairment of normal tissue regenerationToxicity to hematopoietic stem cellsGastrointestinal toxicity due to loss of intestinal stem cell nichesPotential for developmental defects
06

Interacting drugs

Glasdegib

3 more in the full profile.

07

Biomarkers

OCT4 (POU5F1)SOX2NANOGCD133 (PROM1)ALDH1BMI1

Beyond the preview

Go deeper on Cellular self-renewal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular self-renewal.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call